1. Home
  2. PODD vs FTS Comparison

PODD vs FTS Comparison

Compare PODD & FTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • FTS
  • Stock Information
  • Founded
  • PODD 2000
  • FTS 1885
  • Country
  • PODD United States
  • FTS Canada
  • Employees
  • PODD N/A
  • FTS N/A
  • Industry
  • PODD Medical/Dental Instruments
  • FTS Electric Utilities: Central
  • Sector
  • PODD Health Care
  • FTS Utilities
  • Exchange
  • PODD Nasdaq
  • FTS Nasdaq
  • Market Cap
  • PODD 23.8B
  • FTS 24.9B
  • IPO Year
  • PODD 2007
  • FTS N/A
  • Fundamental
  • Price
  • PODD $340.29
  • FTS $49.41
  • Analyst Decision
  • PODD Strong Buy
  • FTS Hold
  • Analyst Count
  • PODD 18
  • FTS 1
  • Target Price
  • PODD $334.50
  • FTS $72.00
  • AVG Volume (30 Days)
  • PODD 532.2K
  • FTS 533.6K
  • Earning Date
  • PODD 11-06-2025
  • FTS 11-04-2025
  • Dividend Yield
  • PODD N/A
  • FTS 3.56%
  • EPS Growth
  • PODD N/A
  • FTS 6.60
  • EPS
  • PODD 3.32
  • FTS 2.49
  • Revenue
  • PODD $2,359,500,000.00
  • FTS $8,705,438,970.00
  • Revenue This Year
  • PODD $29.18
  • FTS $14.41
  • Revenue Next Year
  • PODD $18.09
  • FTS $4.77
  • P/E Ratio
  • PODD $102.63
  • FTS $19.77
  • Revenue Growth
  • PODD 26.00
  • FTS 4.22
  • 52 Week Low
  • PODD $225.37
  • FTS $40.32
  • 52 Week High
  • PODD $353.50
  • FTS $51.45
  • Technical
  • Relative Strength Index (RSI)
  • PODD 59.53
  • FTS 47.88
  • Support Level
  • PODD $336.00
  • FTS $48.64
  • Resistance Level
  • PODD $351.94
  • FTS $49.98
  • Average True Range (ATR)
  • PODD 8.16
  • FTS 0.50
  • MACD
  • PODD -1.50
  • FTS -0.10
  • Stochastic Oscillator
  • PODD 46.37
  • FTS 47.06

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About FTS Fortis Inc.

Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving roughly 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.

Share on Social Networks: